Target
colony stimulating factor receptor Type 1 (CSF-1R)
4 abstracts
Abstract
ImmunoSarc II master trial (phase II of sunitinib and nivolumab): Results from the dedifferentiated chondrosarcoma (DDCS) cohort—A GEIS, ISG and UCL study.Org: University College London Hospital NHS Trust and Great Ormond Street Hospital, Health Research Institute-Fundación Jiménez Díaz University Hospital, Autonomous University of Madrid (IIS-FJD, UAM), IRCCS Istituto Ortopedico Rizzoli, Hospital Universitario Miguel Servet,
Abstract
The real-world impact of next-generation sequencing in advanced stages of solid tumor malignancies.Org: Orlando Health Cancer Institute, University of South Florida Morsani College of Medicine, Comprehensive Hematology-Oncology,
Abstract
A smart clinical cohort selection system for clinical oncology research.Org: FAST National University of Computer and Emerging Sciences, CureMD Inc,
Abstract
Changes in time to treatment initiation for patients diagnosed with breast, lung, colon, or rectal cancer during the 2020 COVID-19 pandemic in the US.Org: American Cancer Society, Atlanta, GA, Case Western Reserve University School of Medicine, Cleveland, OH,